Tag: pharmaceuticals
-
Patent Awarded for Nasal Delivered Cancer Immunotherapy
A technology for cancer therapies that harnesses the immune system with nanoscale droplets suspended in an emulsion and delivered through the nose received a U.S. patent.
-
Immunotherapy Trial Shows Increased Brain Cancer Survival
Results from a clinical trial show an experimental treatment for an aggressive form of brain cancer that harnesses the immune system extends patients’ survival, when combined with standard cancer care.
-
New ALS Drug Formula Shown Active, Safe
A new formulation of a current drug to treat amyotrophic lateral sclerosis, or ALS, shows in its first clinical trial the drug produces more active ingredients against ALS than the current drug and causes no safety concerns.
-
FDA Urges More Industry Sun Protection Research
The head of the U.S. Food and Drug Administration is asking companies making sunscreen to conduct more research on the safety of products that protect against harmful sun rays.
-
Long-Term Effects Shown from Hemophilia Gene Therapy
Participants in a clinical trial testing a one-time genetic therapy to treat a rare form of hemophilia sharply reduced their bleeding incidents after a year, with few adverse effects, none considered serious.
-
Gene Therapy Safety Study for Heart Failure Underway
An early-stage clinical trial is testing gene therapy to treat malfunctioning heart muscle cells in people with heart failure, where the heart cannot pump enough blood for the body.
-
Medicine Man – The Future of Pharma Testing
Being able to remove animals and people from the testing process can make it all much easier, while also limiting the risks to those involved.
-
Cannabis Derivative Shown to Reduce Severe Seizures
A clinical trial shows treatments made with cannabidiol, a medical-grade derivative of cannabis plants, reduce the number of severe seizures in people with Lennox–Gastaut syndrome, when combined with conventional drugs.
-
Clinical Trials Okayed for Sickle Cell Gene Editing
Two companies developing therapies for inherited blood disorders say the Food and Drug Administration approved their application to begin clinical trials of treatments for sickle cell disease with gene editing.
-
Genetic Repair Company Starts-Up, Gains $87 Million
A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA.